newwin
Luciann Nguyen
Settings
← Accounts
academic

Dana-Farber Cancer Institute

32
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

Dana-Farber Cancer Institute

New trial — Biology of Young Lung Cancer Study: The YOUNG LUNG Study

New trialNCT05265429
32/100
Opportunity
Commercial fit0/25
Clinical timing13/20
Biomarker need0/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5

New unknown trial NCT05265429 posted by Dana-Farber Cancer Institute: "Biology of Young Lung Cancer Study: The YOUNG LUNG Study". New trial on a unknown recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 314 days ago.

ConfidenceHigh · 80%clinical development · translational medicine · clinical operations
Draft outreachReview

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Trials

TrialPhaseTesting language
NCT05265429
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
unknown
—